ethyl N-[1-[4-fluoro-3-(trifluoromethyl)phenyl]cyclopropyl]-N-[[(2S)-pyrrolidin-2-yl]methyl]carbamate

ID: ALA4743839

Chembl Id: CHEMBL4743839

PubChem CID: 155699165

Max Phase: Preclinical

Molecular Formula: C18H22F4N2O2

Molecular Weight: 374.38

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCOC(=O)N(C[C@@H]1CCCN1)C1(c2ccc(F)c(C(F)(F)F)c2)CC1

Standard InChI:  InChI=1S/C18H22F4N2O2/c1-2-26-16(25)24(11-13-4-3-9-23-13)17(7-8-17)12-5-6-15(19)14(10-12)18(20,21)22/h5-6,10,13,23H,2-4,7-9,11H2,1H3/t13-/m0/s1

Standard InChI Key:  YVOFLKTZUCOJLS-ZDUSSCGKSA-N

Alternative Forms

1. Parent:

   

   ALA4743839

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 374.38

Molecular Weight (Monoisotopic): 374.1617

AlogP: 4.04

#Rotatable Bonds: 5

Polar Surface Area: 41.57

Molecular Species: BASE

HBA: 3

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 10.55

CX LogP: 3.63

CX LogD: 0.74

Aromatic Rings: 1

Heavy Atoms: 26

QED Weighted: 0.79

Np Likeness Score: -0.69

References

1. Blass BE..  (2020)  Novel Potassium Channel Inhibitors.,  11  (12.0): [PMID:33335651] [10.1021/acsmedchemlett.0c00569]

Source

Source(1):

• Scientific Literature